Guruvigneshwari M, Vijaya Bharathi R, Radha R, Sooriyapriya B
Guruvigneshwari M*, Vijaya Bharathi R, Radha R, Sooriyapriya B
Department of Pharmacognosy, College of Pharmacy, Madras Medical College, Chennai 3.
Volume - 15,
Issue - 3,
Year - 2022
Objective: To find out the xanthine oxidase inhibitory potential of constituents reported from the Abutilon indicum through in silico studies as there is traditional claim supporting the use of this plant in treating gout. Method: The 33 constituents of Abutilon indicum were chosen for the study and their drug likeness were read using online application SwissADME. Molecular docking studies were done in Autodock version 1.5.6. The docked samples were viewed using Molegro Molecular Viewer 2.5.0. and Pymol. Allopurinol was used as standard to compare the docking scores of the plant constituents. Results: All the 33 compounds (A1-A33) exhibited drug likeness. Good binding energies were observed for 19 constituents against 3AX7 protein. 6 compounds such as luteolin, beta-amyrin,1-lycoperodine, chrysoeriol, quercetin and flavone possessed binding energies greater than 8 and good inhibition constant values. Conclusion: The constituents of Abutilon indicum has good xanthine oxidase inhibiting potential and can further be developed into a drug candidate against gout.
Cite this article:
Guruvigneshwari M, Vijaya Bharathi R, Radha R, Sooriyapriya B. In silico Inhibition studies of constituents of Abutilon indicum on Xanthine oxidase. Research Journal of Pharmacy and Technology. 2022; 15(3):1133-6. doi: 10.52711/0974-360X.2022.00190
Guruvigneshwari M, Vijaya Bharathi R, Radha R, Sooriyapriya B. In silico Inhibition studies of constituents of Abutilon indicum on Xanthine oxidase. Research Journal of Pharmacy and Technology. 2022; 15(3):1133-6. doi: 10.52711/0974-360X.2022.00190 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-3-33
1. Manjuladevi K, Subhash Krishnan R, Rahini P. A Review on Gouty Arthritis. Research Journal of Pharmacy and Technology. 2019; 12(11):5583-5588.
2. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016; 388(10055): 2039-2052.
3. Richette P, Bardin T. Gout. Lancet. 2010; 375(9711): 318-328.
4. Pascart T, Richette P. Current and future therapies for gout. Expert Opinion on Pharmacotherapy 2017;18(12):1201-1211.
5. Smelcerovic A et al. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity. European Journal of Medicinal Chemistry. 2017; 28(135): 491-516.
6. Jain MS, Barhate SD, Gayakwad BP. Probenecid Act as an Uricosuric agent: A Review. Asian Journal of Research in Pharmaceutical Sciences. 2018; 8(1):45-47.
7. Kumar Amit, Krishna Shri, Singh Arjun. Elemental Analysis of Ash and Physico-Chemical Evaluation of Abutilon indicum Linn. – An Important Medicinal Plant. Asian Journal of Research in Chemistry. 2011; 4(8): 1245-1248.
8. Kritikar KR, Basu. BD. Indian Medicinal Plants. Uttarakhand: International book distributors; 2008, p.314-316.
9. Taxonomy of abutilon indicum [Internet]. Chennai (IN): Birla Institute of Scientific Research. c2016 – Cited [2020 Apr 23]. Available from: https://bioinfo.bisr.res.in/project/domap/plant_details/b...
10. Tripathi P, Chauhan NS, Patel JR. Anti-inflammatory activity of Abutilon indicum extract. Natural Product Research. 2012;26(17):1659-1661.
11. Ritesh Jain et al. Anti-inflammatory Action of Abutilon indicum (L.) Sweet Leaves by HRBC Membrane Stabilization. Research Journal of Pharmacy and Technology. 2009; 2(2) : 415- 416.
12. Golwala DK et al. Anti-Inflammatory Activity of Abutilon indicum Linn. Leaf. Research Journal of Pharmacy and Technology. 2010 ; 3(1): 183 – 186.
13. Poonkothai M. Antibacterial Activity of leaf extract of Abutilon indicum. Ancient Science of Life. 2006;26(1-2):39-41.
14. Mata R, Nakkala JR, Sadras SR. Polyphenol stabilized colloidal gold nanoparticles from Abutilon indicum leaf extract induce apoptosis in HT-29 colon cancer cells. Colloidal and Surfaces B: Biointerfaces. 2016;143:499-510.
15. Yasmin S, Kashmiri MA, Asghar MN, Ahmad M, Mohy-ud-Din A. Antioxidant potential and radical scavenging effects of various extracts from Abutilon indicum and Abutilon muticum. Pharmaceutical Biology. 2010;48(3):282-289.
16. Datir SB et al. Evaluation of Antioxidant Activity of the Aerial parts of the Abutilon indicum (Linn) Sweet (Malvaceae). Research Journal of Pharmacology and Pharmacodynamics. 2010; 2(5): 324-327.
17. Porchezhian E, Ansari SH. Hepatoprotective activity of Abutilon indicum on experimental liver damage in rats. Phytomedicine. 2005;12(1-2):62-64.
18. Abdul Rahuman A, Gopalakrishnan G, Venkatesan P, Geetha K. Isolation and identification of mosquito larvicidal compound from Abutilon indicum (Linn.) Sweet. Parasitology Research. 2008;102(5):981-988.
19. Jesurun JRS, Lavakumar S. Nephroprotective effect of ethanolic extract of abutilon indicum root in gentamicin induced acute renal failure. International Journal of Basic & Clinical Pharmacology. 2016; 5(3): 841-845.
20. Parmar DN, Sachdeva PD, Kukkar MR. Evaluation of protective role of Abutilon Indicum in Aluminium chloride induced Alzheimer’s disease in Rats. Journal of Pharmaceutical Science and Bioscientific Research 2017; 7(5): 314-321.
21. Roshan S, Ali S, Khan A, Tazneem B, Purohit MG. Wound Healing activity of Abutilon Indicum. Pharmacognosy Magazine 2008; 4(15): S85- S88.
22. Shrikanth VM, Janardhan B, More SS, Muddapur UM, Mirajkar KK. In vitro anti snake venom potential of Abutilon indicum Linn leaf extracts against Echis carinatus (Indian saw scaled viper). Journal of Pharmacognosy & Phytochemistry 2014; 3(1): 111-117.
23. Golwala DK, patel LD, Vaidya SK, Bothra SB, Mani M, Patel P. Anticonvulsant activity of Abutilon indicum leaf. International Journal of Pharmacy and Pharmaceutical sciences. 2010; 2(1): 66-71.
24. Gunasekaran B, Muralidharan P. Antinociceptive effect of Abutilon indicum Linn Leaf Extract. Research Journal of Pharmacy and Technology. 2009; 2(3): 544-547.
25. Krisanapun C, Lee SH, Peungvicha P, Temsiririrkkul R, Baek SJ. Antidiabetic Activities of Abutilon indicum (L.) Sweet Are Mediated by Enhancement of Adipocyte Differentiation and Activation of the GLUT1 Promoter. Evidence Based Complement Alternative Medicine. 2011; 2011: 167684.
26. Mohite MS et al. Review on Pharmacological Properties of Abutilon indicum. Asian Journal of Pharmaceutical Research. 2012; 2(4): 156- 160.
27. The Ayurvedic Pharmacopoeia of India. Ayush Govt of India. 1(pt 1): 25-26.
28. Rajput AP, Patel MK. Isolation and characterisation of phytoconstituents from the chloroform extract of Abutilon indicum leaves (Family: Malvaceae). Asian Journal of Research in Chemistry. 2012; 5(11): 1375-1380.
29. Ramasubramaniaraja R. Pharmacognostical Phytochemical Including GC-MS Investigation of Ethanolic Leaf Extracts of Abutilon indicum Linn. Asian Journal of Pharmaceutical Analysis. 2011; 1(4): 88-92.
30. Gaikwad S, Mohan Gk, Reddy K. Proximal Analysis and Preliminary Phytochemical Standardisation of Leaves of Two Malvaceous Plants. Research Journal of Pharmacognosy and Phytochemistry. 2011; 3(5): 211-216.
31. Kuo PC, Yang ML, Wu PL, et al. Chemical constituents from Abutilon indicum. Journal of Asian Natural Products Research. 2008; 10(7-8): 699-703.
32. Rajalakshmi PV, Senthil KK. Direct HPLC analysis of quercetin in exudates of Abutilon indicum (Linn). Malvaceae. Journal of Pharmaceutical Science & Technology. 2009; 1 (2): 80-83.
33. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics [Internet]. Chennai (IN): The Institute of Mathematical Sciences (IMSc).c2020 – Cited [2020 Sept24]. Available from: https://cb.imsc.res.in/imppat/home
34. Khare CP . Indian Medicinal Plants An Illustrated Dictionary. Newyork: Springer; 2007, p.3-4.
35. The Wealth of India, Raw Materials, First Suppl ser. Newdelhi: National Institute of Science Communication & Information Resources; 2000, p.7.
36. Matławska I, Sikorska M. Flavonoid compounds in the flowers of Abutilon indicum (L.) Sweet (Malvaceae). Acta Poloniae Pharmaceutica. 2002; 59(3): 227-9.
37. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews. 1997 ; 23: 3-25.
38. Buvana C, Sumathy A, Sukumar M. In silico Identification of Potential Xanthine Oxidase inhibitors for the Treatment of Gout and Cardiovascular Disease. Asian Journal of Research in Chemistry. 2013; 6(11): 1049-1053.